Methods

Expression and purification of the CP for NMR
All constructs based on CP α-and β-subunits were produced by mutagenesis using the QuikChange site-directed mutagenesis kit (Stratagene) where the α-subunit (β-subunit) was fused to an N-terminal, TEV-cleavable His-tag in the pETM-11 vector (fused to an N-terminal, TEV-cleavable, NusA, His-tag in the pETM-60 vector). The only exception was the βT1A-GM sample, as described in Fig. 2A in which β has a two residue "Gly-Met" prosequence, where the β-subunit was expressed as a fusion protein with a non-cleavable C-terminal His-tag. The standard construct with an N-terminal fusion tag could not be used in this case because TEV protease is unable to access its recognition site when it is placed too close to the N-terminus of the β-subunit. For samples in which methyl groups of the α-subunit were labeled, the β-subunits were expressed in Luria broth. For samples with methyl labeling of the β-subunit, the α-subunit was produced with [ 12 C, 2 H] labeling. (The difference reflects the fact that the α-subunit expresses in much high quantities relative to β so that it is far cheaper to produce 2 H labeled α-subunit than the correspondingly labeled β-subunit).
Expression and purification of 11S
An N-terminal His-tag construct of the 11S regulatory particle in a pProEX vector was expressed sodium chloride and α-synuclein eluted at a sodium chloride concentration of 250-300 mM. Next, the volume of the α-synuclein containing solution was reduced using a concentrator with a 3 kDa-cutoff, the entire solution was diluted 1:1 with a stock solution of 8 M guanidine-HCl, 0.1% TFA, and loaded onto a Phenomenex Gemini C 18 HPLC column (10 mm × 25 cm, 5 µm particle size) that was equilibrated with 0.1% TFA, 0% acetonitrile. α-synuclein was eluted by applying a 25-75% gradient of 100% acetonitrile, 0.1% TFA over 45 mL at 4 mL/min, and the fractions containing the protein were lyophilized and stored at -20 o C until further use.
Chloroquine binding
Concentrated (200 mM) stock solutions of chloroquine were prepared by dissolving chloroquine diphosphate salt into 25 mM potassium phosphate pH 6.7, 50 mM sodium chloride, 0.03% azide, 1 mM EDTA, 99.9% D2O (which will subsequently be referred to as standard NMR buffer) and adjusting the pH to 6.7 by addition of NaOD. Chloroquine was diluted from this stock solution into 800 µM (400 µM) samples of the CP that are methyl labeled in the α-subunit (β-subunit) to give equimolar concentrations of chloroquine and α-or β-subunit. Chloroquine binding was not saturated, as this would require concentrations of chloroquine that are similar to that of the buffer components (1) . Under the conditions used here, chemical shifts reflect the structure of the chloroquine-CP complex and are not complicated from non-specific salt effects. Free and chloroquine-bound CP are in fast exchange on the NMR chemical shift timescale and therefore a single resonance is observed for each methyl group peak that corresponds to a population-weighted average of the chemical shifts of the free and chloroquinebound CP forms. 1D 1 H NMR spectra were acquired for chloroquine dissolved in standard NMR buffer before and after incubation for ~16 h at 70 o C, analogous to the conditions used for NMR experiments on the CP-chloroquine samples, to ensure that the small molecule was stable and did not degrade.
Saturation transfer measurements
HMQC-based saturation transfer experiments similar to those published previously (2) The pulse sequence for this experiment was based on the standard HMQC scheme used to acquire 13 C, 1 H correlation maps that exploits a methyl-TROSY effect (3). Saturation was achieved using a WURST-2 decoupling scheme (4) with a 2 ppm bandwidth and was applied for a total duration of 500 ms. Spectra were acquired as described in the main text.
RDC measurements
The use of alignment media degrades spectral quality somewhat due to the invariable introduction glucose). The precursor was purchased as an ester that was hydrolyzed by base catalysis several hours prior to its addition into growth media. Briefly, 186 mg of the precursor was dissolved in 9 mL of 75 mM sodium phosphate, pH 6.6. Hydrolysis of the ester occurred upon addition of 1.5 molar equivalents of NaOH, upon which the pH increased to 12.2 and then dropped over the next 10 min and stabilized at 11.6. The reaction was quenched upon addition of HCl in quantities sufficient to decrease the pH to 7.4.
The extent of the reaction was assessed from 1D 1 H NMR spectra where it was evident that the ester was completely hydrolyzed.
RDC measurements were performed for αL81V and βT1A-pro CP variants on samples that were 750 µM and 900-1000 µM for β and α methyl-labeled CPs, respectively (concentrations reflect that of the β-or α-subunit, measurements were conducted at 18.8 T, 70 o C, for CPs suspended in standard NMR buffer). For measurements of J methyl values, corresponding to the one-bond 13 C-1 H scalar coupling constant, an HMQC-based pulse sequence was used (7) as described in some detail in the legend to Fig.   S6 , with measurement times of at least 12 h. Next, alignment was introduced upon introduction of Pf1-filamentous phage. 10 mg of phage (purchased from Asla biotech) was transferred to the buffer used for NMR measurements of CP samples via a centrifugation method (phage was pelleted by 2 h centrifugation at 55 rpm in a Beckman 70 Ti rotor, followed by resuspension into the standard NMR buffer; this process was repeated 3 times to ensure that the original buffer was diluted at least 10,000-fold 
Proteolysis assays
α-synuclein, CPs, and the 11S regulatory particle used in proteolysis assays were produced by expression in Luria broth. Stocks of all proteins were prepared in a buffer that had analogous components to the standard NMR buffer but based in H 2 O. Proteolysis reactions were conducted by incubating 200 µL reactions that contained 300 µM α-synuclein mixed with 300 nM CP complex (or in the case of 11S-bound CPs, 300 nM WT CP and 1.2 µM 11S complex that were pre-mixed prior to addition to a solution containing α-synuclein). Reactions were incubated for 30 min at 50 o C in a PCR machine with a pre-heated lid (99 o C) so that no sample evaporation occurred. Degradation reactions were quenched by denaturing protein components by adding guanidine-HCl to 5.6 M and TFA to 0.1%.
Reactions were frozen until analysis by reverse phase (RP) HPLC, for which the entire volume was injected onto a C 18 Beckman ultrasphere column (4.6 mm × 25 cm, 5 µm particle size) that was equilibrated with 5% acetonitrile, 0.1% TFA. Degradation products were separated by running a gradient from 0 to 60% of elution buffer containing 95% acetonitrile, 0.08% TFA that was applied over 60 min at 1 mL/min. The α-and β-subunits eluted at higher concentrations of elution buffer and were removed by subsequent washing of the column with 100% elution buffer for 10 min. Peptides were detected by absorbance at 214 nm. To identify peptides in HPLC profiles, fractions were collected every 0.25 mL and those containing peptides were lyophilized and re-dissolved in 50% acetonitrile for analysis by electrospray mass spectrometry.
Assignment of the isolated β-subunit
Triple resonance methods were used to assign 63 out of 73 methyl group peaks for the 22 kDa . The construct of the isolated β-subunit that was assigned had two modifications relative to the wild type subunit that were necessary to augment the stability of samples. These included (1) mutation of the active site (βT1A) and (2) conjugation of a tag to the Nterminus that included the amino acid sequence "DDDDDDDDD", which increased the solubility of the protein by nearly an order of magnitude and decreased aggregation.
Transfer of assignments from the isolated β-subunit to β assembled in the CP
The environment of methyl groups localized to the core of the β-subunit and the structure in which they are located are closely analogous for β in the context of the CP and the subunit in isolation.
Therefore, the assignments for such peaks (~40%) could be transferred on the basis of chemical shift similarity and through the analysis of 3D NOE spectra (HMQC-NOESY-HMQC), making use of the Xray structure of the CP (14). Note that the NOE data sets record the 13 C chemical shift of the methyl group from which magnetization originates and the 13 C, 1 H shifts of the methyl groups that serve as the sites of transfer, 250 ms. NOE spectra were obtained on CP samples with standard ILV-methyl labeling (6, 15, 16) in which only one of the two pro-chiral methyl groups is labeled in a non-stereospecific manner (3 mM in the β-subunit). These data were supplemented with NOE spectra from CPs in which only one of the two methyl groups on each Leu,Val side chain was labeled but in a pro-chiral manner (5) ( interpretation of NOE patterns. Assignments for peaks that could not be transferred from the isolated β-subunit were determined from a combination of mutagenesis and analysis of NOE patterns in concert with distances between methyl groups measured from the crystal structure of the CP (14). The following CP β-subunit mutants were used for the assignment process: V4I, V20A, I26V, l34I, L48A, V49A, V54A, L55I, V56I, L65I, V72I, L82I, L87M, V90S, L100I, V120I, I123V, V134A, V137I, L138I, V152I, and V175I. Peaks were assigned for 72 of the 73 methyl groups in CP spectra, including stereospecific assignments for Leu/Val pro-chiral methyls. 18.8 T. The β-subunit was produced using standard methods for labeling Ile, Leu, and Val sidechains (2) . A domain-parsing approach was used for assignment in a manner analogous to that reported V4-γ2 
where i={ 13 C, 1 H} and Δν i is the shift difference (Hz, between αL81 mutant and WT CPs) in each dimension. This quantity was computed for every resolved peak in αL81 CP spectra and is shown for (A) αL81A and (B) αL81V CPs. The secondary structure elements on which the methyl group probes are located are indicated along the X-axis. It is clear that the same methyl groups shift in the two samples and that for any given peak the relative magnitude of the displacement is greater for αL81V than for αL81A. C) The direction of peak displacement was compared for corresponding methyl groups in the two αL81 mutant CPs relative to the WT as a renormalized dot product. This quantity is analogous to the vector dot product that is used to measure the angular relationship between vectors, and in this case is derived from chemical shift differences:
where ν is the chemical shift in the carbon or proton dimensions for the indicated sample, X = A or V (i.e., αL81A or αL81V) and
The renormalized dot product has values between -1 and 1 with 1 corresponding to the case when the peaks are displaced in the same direction and -1 when they are displaced in opposite directions. D) The directions of peak displacement were quantitatively compared via the renormalized dot product, which was calculated for every peak in the spectrum of αL81A and αL81V CPs for which norm > 5 Hz.
Clearly, peaks are displaced in the same directions in the two mutant CPs. Taken together, the above data indicate that αL81 mutations result in related conformational changes to the β-subunit. The β-subunit is in fast exchange between 2 or more conformers and the effect of the mutation is to shift the position of this equilibrium. The change in the relative conformer populations is larger for the αL81V CP than for the αL81A CP. are located at least 10 Å away from the site of mutation, as measured by "norm", which is described in the legend of Fig. S2 . C) Comparison of the direction of peak displacements for αL81V and αL81A CPs via the renormalized dot product, which was calculated as described in the legend of Fig. S2 . The majority of peaks are perturbed in the same direction in the two CP mutants and with relative magnitudes αL81V > αL81A. D) Methyl groups in the αL81V and αL81A CPs that do not shift analogously predominately localize to secondary structure elements such as β-strands αS3 and αS4 that are directly adjacent to αH1 on which αL81 is located. These structural elements (αH1, black; αS3 and αS4, grey; methyl group probes on αS3 and αS4 whose displacements are not positively correlated, pink) are shown in the context of the structure of a single α-subunit (green). Although 'non-analogous' shifts extend to methyl groups more than 10 Å from the site of mutation, these changes are not unreasonable in the context of the structure. In summary, chemical shifts as reported by the majority of methyl groups in the α-subunit respond to the introduction of mutations at αL81 in a manner that is analogous to chemical shifts reported by methyl groups in the β-subunit. The entire CP is in fast exchange between multiple conformers and the effect of mutations at αL81 is to change the population distribution of these exchanging conformers. CP variants, with the only significant difference in the case of the α-subunit occurring for αI157, which is significantly perturbed for the βT1A-pro CP but not for the βT1C CP. Moreover, the directions by which chemical shifts are perturbed are essentially identical, as quantitated by the renormalized dot product (C,F) for analysis of methyl groups in the β-and α-subunits, respectively. Therefore, although altered gate populations were observed for βT1A-pro but not βT1C CPs (Fig. 2C-D) , similar perturbations are observed globally to the CP structure in both the α-and β-subunits. Gate opening may result from differential changes in a small sub-sector of the CP structure in which methyl probes are not available or alternatively may involve a mechanism distinct from what is quantified in the present study.
One possibility is that βT1A-pro and βT1C mutants exert different effects on αH0. This helix and the reverse turn, located proximal to the gate, undergo changes upon activator-mediated gate opening (1, 2) and αH0 has been crystallized in multiple conformations for the isolated CP from Mycobacterium tuberculosis (3). G) αH0 (αL21δ2, αV24γ2), as well as αL81δ1, αV129γ2, and αI12δ1 that are located on structures contacting it, exhibit multiple conformations that are in slow exchange on the NMR timescale (second timescale). This behavior is very much analogous to what was observed for gate conformations (4) (magnetization exchange data not shown). As the conformational changes occurring to other parts of the CP are observed to be in fast exchange on the NMR timescale, differing by more than 3 orders of magnitude from the slow exchange described here, there may be a decoupling of structural changes at the level of αH0 from those that are observed in other regions of the CP.
Regrettably, the effects on αH0 are difficult to compare quantitatively between CP samples because peaks in this region are broadened from a ms exchange process (T. L. Religa and L. E. Kay, unpublished data), leading to lower S/N than for other correlations in the spectrum. although the reason for this is unknown, it is worth pointing out that even in these cases the direction of peak movement is still related in the two samples. is what is expected in the case where RMSDs reflect experimental error and not differences in structure.
Therefore, the structural differences between the CP variants are likely to be subtle. One possibility is that the CP conformations are related by a rigid body rotation of β-or α-subunits; this type of conformational change has been used to characterize allostery in many oligomeric regulatory enzymes experiments (25 mM potassium phosphate, 50 mM sodium chloride, pH 6.7). To quench reactions, 4 reaction volumes of a stock solution of 7.0 M guanidine-HCl, 0.1% TFA was added, and subsequently peptide cleavage products were separated using reverse phase (RP) HPLC. A) RP-HPLC profiles were compared for degradation reactions with the different CP variants, as well as for an additional control sample where α-synuclein was incubated without addition of CP. All profiles exhibit a dominant peak that corresponds to fully intact α-synuclein; this is because reactions were conducted with 1000-fold molar excess substrate over CP for sufficiently short reaction times (30 min) so that only ~10% of the substrate was degraded. Expansion of the Y-axis (inset, corresponding to the area enclosed by the dashed box) reveals a series of peaks that elute between 15 and 58 min that correspond to different peptide degradation products. Peaks from reactions with different CP variants are described by a common set of retention times, but with variable peak intensities. This indicates that the same set of peptide degradation products are produced, but that the propensity for specific amino acid sequences to be cleaved and therefore the relative amounts of the products obtained depend on the CP type. Notably, the cleavage pattern is related to the average time that the various amino acid sequences of the substrate occupy the active site (1). B) Further RP-HPLC analysis of α-synuclein degradation products produced upon incubation with WT CPs reveals that the peak pattern is stable over time, varying only in the absolute quantity of peptides generated. Reactions were conducted analogously to above but for 20, 30
or 40 min incubation times. The amounts of dominant peptide products increase linearly with incubation time. With the reaction set up used, the degradation products result from processing of fully intact α-synuclein by the CP and not from re-entry and further cleavage of products after their initial exit (2-4).
C) α-synuclein degradation products were determined for the dominant peaks in RP HPLC profiles using electrospray mass spectrometry. The full sequence of α-synuclein is shown with the peptide degradation product corresponding to the portion of the sequence colored in red. Peaks 1, 2, 3, and 6
give mass spectra that contain a dominant product, while peaks 4 and 5 contain several distinct peptides with related compositions. α-synuclein is 140 amino acids long and the number of cleavage products produced is sufficiently large (and each product is produced in a sufficiently small quantity) to prohibit resolution and quantitation of some products by RP-HPLC (e.g. peaks that elute between 15 and 27 min) (3). Nevertheless, from the dominant peaks that consist primarily of a single peptide, it is evident that the relative amounts of proteolysis products are altered (see Fig. 6B for expansion). D) αL81A and αL81V CPs have the same relative populations of "in" vs. "out" states of the gate as WT CPs.
Therefore, the mean residence time for substrate would be expected to be very similar for these 3 CP variants. The difference in cleavage products that are produced in these cases (see also 
